Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study Assessing the Safety, Efficacy and Treatment Adherence of Nevirapine Extended Release (Combined With Other Antiretroviral Drugs) in HIV Infected Patients in Daily Clinical Practice

NCT01524900 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01524900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01524900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study Assessing the Safety, Efficacy and Treatment Adherence of Nevirapine Extended Release (Combined With Other Antiretroviral Drugs) in HIV Infected Patients in Daily Clinical Practice
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2014
Enrollment
398 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections